Link Details
- Metabolite
- HMDB0001539 (Asymmetric dimethylarginine)
- DrugBank ID
- DB00584
- Drug Name
- Enalapril
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Delles C, Schneider MP, John S, Gekle M, Schmieder RE: Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens. 2002 Jul;15(7 Pt 1):590-3. [PubMed:12118904 ]
- Napoli C, Sica V, de Nigris F, Pignalosa O, Condorelli M, Ignarro LJ, Liguori A: Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J. 2004 Jul;148(1):e5. [PubMed:15215814 ]